tiprankstipranks
OKYO Pharma Accelerates Urcosimod Development for Neuropathic Corneal Pain
PremiumCompany AnnouncementsOKYO Pharma Accelerates Urcosimod Development for Neuropathic Corneal Pain
2M ago
Okyo Pharma announces plans to accelerate development of urcosimod
Premium
The Fly
Okyo Pharma announces plans to accelerate development of urcosimod
2M ago
OKYO Pharma Achieves Key Stability Milestone for Urcosimod
Premium
Company Announcements
OKYO Pharma Achieves Key Stability Milestone for Urcosimod
3M ago
OKYO Pharma’s Lead Asset OK-101 Receives USAN as Urcosimod
PremiumCompany AnnouncementsOKYO Pharma’s Lead Asset OK-101 Receives USAN as Urcosimod
5M ago
Okyo Pharma announces OK-101 officially assigned USAN, urcosimod
Premium
The Fly
Okyo Pharma announces OK-101 officially assigned USAN, urcosimod
5M ago
Yi Chen’s Buy Recommendation on OKYO Pharma: Promising Potential of OK-101 for Neuropathic Corneal Pain Amid Financial and Regulatory Challenges
Premium
Ratings
Yi Chen’s Buy Recommendation on OKYO Pharma: Promising Potential of OK-101 for Neuropathic Corneal Pain Amid Financial and Regulatory Challenges
5M ago
OKYO Pharma Secures $1.4 Million to Boost Ophthalmic Innovations
PremiumCompany AnnouncementsOKYO Pharma Secures $1.4 Million to Boost Ophthalmic Innovations
6M ago
Okyo Pharma receives $1.4M in non-dilutive financing
Premium
The Fly
Okyo Pharma receives $1.4M in non-dilutive financing
6M ago
OKYO Pharma to Highlight Innovations at BTIG Conference
Premium
Company Announcements
OKYO Pharma to Highlight Innovations at BTIG Conference
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100